Ataxia-telangiectasia surveyed in Sweden;Ataxia-telangiectasia kartlagd i Sverige

Lakartidningen

Volumn 97, Issue 40, 2000, Pages 4461-4467

  Lähdesmäki, Aleksi ^a   Arinbjarnarson, Kristian ^b   Arvidsson, Jan ^c   El Segaier, Milad ^d   Fasth, Anders ^e   Fernell, Elisabeth ^a   Gustafsson, Dan ^f   Oxelius, Vivi Anne ^g   Risberg, Knut ^b   Yuen, Jonathan ^h   Zetterlund, Per ⁱ   Von Zweigbergk, Monika ^j   Åhsgren, Ingegerd ^k   Hammarström, Lennart ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Skellefteå Lasarett ^*  (Sweden)

^c Barn och Ungdomshabiliteringen   (Sweden)

^d MAS   (Sweden)

^e QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^f Regionsjukhuset   (Sweden)

^g LUND UNIVERSITY HOSPITAL   (Sweden)

^h SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

ⁱ Kristianstadkliniken   (Sweden)

^j NUS   (Sweden)

^k Barn och Ungdomsneurohabilitering

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATAXIA TELANGIECTASIA; CHILD; CHROMOSOME 11; DISEASE PREDISPOSITION; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOLOGY; INFANT; MALE; MUTATION; NEWBORN; PHENOTYPE; PRESCHOOL CHILD; RISK FACTOR; SWEDEN;

ADOLESCENT; ADULT; ATAXIA TELANGIECTASIA; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 11; DISEASE SUSCEPTIBILITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUTATION; PHENOTYPE; RISK FACTORS; SWEDEN;

EID: 0034605416     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Syllaba K, Henner K. Contribution a l'independance de l'athetose double idiopathique et congenitale. Atteinte familiale, syndrome dystrophique, signe de reseau vasculaire conjonctival, integrite psychique. Rev Neurol 1926; 1: 541-62.
2. Boder E, Sedgwick RP. Ataxia-telangiectasia. A familial syndrome of progressive cerebellar ataxia, oculocutaneuos telangiectasia and frequent pulmonary infection. A preliminary report on 7 children, an autopsy, and a case history. University of Southern California Medical Bulletin 1957; 9: 15-28.
3. Biemond A. A palaeocerebellar atrophy with extra-pyramidal manifestations in association with bronchiectasias and telangiectasias of the conjuctiva bulbi as a familial syndrome. Proceedings in the 1st International Congress in Neurological Sciences, Brussels. L van Bogaert, J Radermecker, eds. London: Pergamon, 1957; 206-10.
4. Shiloh Y. Ataxia-telangiectasia: closer to unraveling the mystery. Eur J Hum Genet 1995; 3: 116-38.
5. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995; 268: 1749-53.
6. Savitsky K, Sfez S, Tagle DA, Ziv Y, Sartiel A, Collins FS et al. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 1995; 11: 2025-32.
7. Inskip HM, Kinlen LJ, Taylor AMR, Woods CG, Arlett CF. Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia. Br J Cancer 1999; 79: 1304-7.
8. Gatti RA, Berkel I, Boder E, Braedtd G, Charmley P, Concannon P et al. Localization of an ataxia-telangiectasia gene to chromosome 11q22-q23. Nature 1988; 336: 557-80.
9. Shafman T, Khanna KK, Kedar P, Spring K, Kozlov S, Yen T et al. Interaction between ATM protein and c-abI in response to DNA damage. Nature 1997; 387: 520-3.
10. Khanna KK, Keating KE, Kozlov S, Scott S, Gatei M, Hobson K et al. ATM associates with and phosphorylates p53: mapping the region of interaction. Nat Genet 1998; 20: 398-400.
11. Laake K, Telatar M, Geitvik GA, Hansen RO, Heiberg A, Andresen AM et al. Identical mutation in 55% of the ATM alleles in 11 Norwegian AT families: evidence for a founder effect. Eur J Hum Genet 1998; 6(3): 235-44.
12. Gilad S, Chessa L, Khosravi R, Russell P, Galanty Y, Piane M et al. Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am J Hum Genet 1998; 62(3): 551-61.
13. Morrell D, Cromartie E, Swift M. Mortality and cancer incidence in 263 patients with ataxia telangiectasia. J Natl Cancer Inst 1986; 1(77): 89-92.
14. Easton DF. Cancer risks in A-T heterozygotes. Int J Radiat Biol 1994; 66: 177-82.
15. Laake K, Ødegård Å, Ikdahl Andersen T, Bukholm IK, Kåresen R, Nesland JM et al. Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM. Genes Chromosomes Cancer 1997; 18: 175-80.
16. Vorechovsky I, Luo L, Dyer MJ, Amlot PL, Yaxley JC, Foroni L et al. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukemia. Nat Genet 1997; 17(1): 96-9.
17. Stankovic T, Weber P, Stewart G, Bedenham T, Murray J, Byrd PJ et al. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet 1999; 353: 26-9.
18. Bebb G, Glickman B, Gelmon K, Gatti R. »AT risk» for breast cancer. Lancet 1997; 349: 1784-5.
19. Janin N, Andrieu N, Ossian K, Laugé A, Croquette MF, Griscelli C et al. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families. Br J Cancer 1999; 80: 1042-5.
20. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F et al. ATM-deficient mice: A paradigm of ataxia telangiectasia. Cell 1996; 86: 159-71.